The chart below shows how ACCD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ACCD sees a -3.95% change in stock price 10 days leading up to the earnings, and a -12.82% change 10 days following the report. On the earnings day itself, the stock moves by +0.81%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Revenue Exceeds Expectations: Revenue for the quarter was $106.4 million, exceeding the top of our range, while adjusted EBITDA was well ahead of guidance.
Quarterly Cash Generation: We generated a little bit more than $3 million of cash this quarter.
Guidance Affirmation Strengthened: We are affirming our guidance for the year on the strength of these results and the activity within our business.
Cash and Marketable Securities: Cash, cash equivalents, and marketable securities totaled more than $234 million at the end of the second fiscal quarter.
Positive Cash Flow Expectation: We expect to generate positive cash flow on a full-year basis.
Negative
Quarterly Revenue Decline: Revenue for the quarter was $106.4 million, which was below expectations, indicating a decline in sales performance.
Adjusted EBITDA Decline: Adjusted EBITDA was significantly impacted, with a loss of about $4 million expected in Q3, suggesting ongoing financial challenges.
Gross Margin Decline: The gross margin declined sequentially, indicating potential issues with cost management and pricing strategies.
Customer Engagement Decline: There were early signs of reduced customer engagement, with a noted shift in demand patterns that could affect future revenue.
Competitive Pressure in Health Plans: The company is facing increased competition in the health plan sector, which may pressure margins and customer retention efforts.
Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript
ACCD.O
0.43%